In Brief: Female condom
This article was originally published in The Tan Sheet
Executive Summary
Female condom: Female Health Company expects approval in Japan for its female condom during 1998, approximately a year after original forecast. FHC's Japanese partner, Taiho Pharmaceuticals, is conducting clinical trials of the product in Japan and plans to market the condom under the Mylura Femy brand name, FHC says in a recent 10-Q filing with the SEC. There are more than 600 mil. male condom units sold in Japan, with the high number resulting for the most part from the fact that oral contraceptives have never been approved in that country. FHC also notes the South African government recently has ordered 1.5 mil. units of the female condom as part of an agreement with the UN's joint Programme on AIDS. In the U.S., the condom is sold under the trade name Reality. FHC net revenues for the three months ended Dec. 31 were $1.3 mil. compared to $605,818 in the comparable period of 1996. The firm took a net loss of $1.1 mil. compared to a loss of $1.6 mil. in the same quarter a year ago...